Michael Pavlides
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Erratum: Noninvasive assessment of liver disease severity in NAFLD and T2D.
Journal: Hepatology (Baltimore, Md.)
Published: July 17, 2026
Editorial: Prediction of Survival in Hepatocellular Cancer-Rise and Fall of the Machines.
Journal: Alimentary pharmacology & therapeutics
Published: July 08, 2026
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.
Journal: The lancet. Gastroenterology & hepatology
Published: December 21, 2025
Changes in hepatic L-carnitine levels in people with metabolic dysfunction-associated steatotic liver disease (MASLD) assessed by magnetic resonance techniques.
Journal: Scientific reports
Published: December 19, 2025
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study.
Journal: Nature medicine
Published: December 11, 2025
Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitis.
Journal: JHEP reports : innovation in hepatology
Published: November 05, 2025
Association between non-invasive biomarkers and quality of life in Primary Sclerosing Cholangitis.
Journal: PloS one
Published: April 25, 2025
Prospective cohort for early detection of liver cancer (Pearl): a study protocol.
Journal: BMJ open
Published: October 01, 2024
Pilot feasibility study to determine the utility of direct access and quantitative magnetic resonance cholangiopancreatography (MRCP) in the assessment of suspected acute biliary or ductal gallstone presentations.
Journal: BMC gastroenterology
Published: September 20, 2024
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 20, 2024
Severe Dietary Energy Restriction for Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Controlled Trial.
Journal: Journal of cachexia, sarcopenia and muscle
Published: August 08, 2024
Last Updated: 09/26/2026